Successful treatment of Erdheim-Chester disease by interleukin-1 receptor antagonist protein

Joint Bone Spine

Volumn 81, Issue 2, 2014, Pages 175-177

  Courcoul, Audrey ^a   Vignot, Emmanuelle ^a   Chapurlat, Roland ^a  

^a UNIVERSITÉ DE LYON   (France)

Author keywords

Anakinra; Erdheim Chester disease; Histiocytosis; Interleukin 1 receptor antagonist protein

Indexed keywords

ALPHA INTERFERON; C REACTIVE PROTEIN; CORTICOSTEROID; INTERLEUKIN 1BETA; PAMIDRONIC ACID; RECOMBINANT INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; ZOLEDRONIC ACID;

ADULT; ARTICLE; BONE BIOPSY; BONE PAIN; BONE SCINTISCANNING; CASE REPORT; COMPUTER ASSISTED EMISSION TOMOGRAPHY; DEPRESSION; ERDHEIM CHESTER DISEASE; ERYTHROCYTE SEDIMENTATION RATE; HISTIOCYTOSIS; HISTOLOGY; HUMAN; LEG PAIN; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; OSTEOSCLEROSIS; BONE RADIOGRAPHY; MIDDLE AGED; TREATMENT DURATION;

ANAKINRA; ERDHEIM-CHESTER DISEASE; HISTIOCYTOSIS; INTERLEUKIN-1 RECEPTOR ANTAGONIST PROTEIN;

ANTIRHEUMATIC AGENTS; ERDHEIM-CHESTER DISEASE; HUMANS; INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN; MALE; MIDDLE AGED;

EID: 84898547836     PISSN: 1297319X     EISSN: 17787254     Source Type: Journal    
DOI: 10.1016/j.jbspin.2013.06.013     Document Type: Article

References (11)

1. Veyssier-Belot C., Cacoub P., Casparros-Lefebvre D., et al. Erdheim-Chester disease. Clinical and radiological characteristics of 59 cases. Medicine (Baltimore) 1996, 75:157-169.
2. Stoppacciaro A., Ferrarini M., Salmaggi C., et al. Immunohistochemical evidence of a cytokine and chemokine network in three patients with Erdheim-Chester disease: implications for pathogenesis. Arthritis Rheum 2006, 54:4018-4022.
3. Emile J.F., Charlotte F., Amoura Z., et al. BRAF mutations in Erdheim-Chester disease. J Clin Oncol 2013, 31:398. 10.1200/JCO.2012.46.9676.
4. Boissel N., Wechsler B., Leblond V. Treatment of refractory Erdheim-Chester disease with double autologous hematopoietic stem-cell transplantation. Ann Intern Med 2001, 135:844-845.
5. Sheidow T.G., Nicolle D.A., Heathcote J.G. Erdheim-Chester disease: two cases of orbital involvement. Eye 2000, 14:606-612.
6. Braiteh F., Boxrud C., Esmaeli B., et al. Successful treatment of Erdheim-Chester disease, a non-Langerhans-cell histiocytosis, with interferon-a. Blood 2005, 106:2992-2994.
7. Coclet-Ninin J., Dayer J.M., Burger D. Interferon-beta not only inhibits interleukin-1beta and tumor necrosis factor-alpha but stimulates interleukin-1 receptor antagonist production in human peripheral blood mononuclear cells. Eur Cytokine Netw 1997, 8:345-349.
8. Koné-Paut I., Piram M. Targeting interleukin-1b in CAPS (cryopyrin-associated periodic) syndromes: what did we learn?. Autoimmun Rev 2012, 12:77-80. 10.1016/j.autrev.2012.07.026.
9. Tran T.A., Pariente D., Lecron J.C., et al. Treatment of pediatric Erdheim-Chester disease with interleukin-1-targeting drugs. Arthritis Rheum 2011, 63:4031-4032.
10. Aouba A., Georgin-Lavialle S., Pagnoux C., et al. Rationale and efficacy of interleukin-1 targeting in Erdheim-Chester disease. Blood 2010, 116:4062-4070.
11. Aubert O., Aouba A., Deshayes S., et al. Favorable radiological outcome of skeletal Erdheim-Chester disease involvement with anakinra. Joint Bone Spine 2013, 80:206-207. 10.1016/j.jbspin.2012.07.005.